About FidoCure
FidoCure is a company based in Palo Alto (United States) founded in 2016. FidoCure has raised $10 million across 2 funding rounds from investors including Lerer Hippeau, Global Brain and Polaris Partners. The company has 10 employees as of December 31, 2024. FidoCure offers products and services including Genomic Testing Platform and AI-Driven Treatment Recommendations. FidoCure operates in a competitive market with competitors including Volition, Dognosis, MetaDx, Betternostic and CanCan Diagnostics, among others.
- Headquarter Palo Alto, United States
- Employees 10 as on 31 Dec, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Onehealthcompany, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$10 M (USD)
in 2 rounds
-
Latest Funding Round
Not available
-
Investors
Lerer Hippeau
& 6 more
-
Employee Count
10
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of FidoCure
FidoCure offers a comprehensive portfolio of products and services, including Genomic Testing Platform and AI-Driven Treatment Recommendations.
AI system for analyzing dog cancer mutations and recommending therapies.
Platform suggests targeted cancer treatments based on real-world evidence.
Funding Insights of FidoCure
FidoCure has successfully raised a total of $10M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in FidoCure
FidoCure has secured backing from 7 investors, including venture fund investors. Prominent investors backing the company include Lerer Hippeau, Global Brain and Polaris Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global Brain is recognized as a venture capital firm supporting startups.
|
Locked | Locked | Locked | |
|
US focused venture capital firm
|
Locked | Locked | Locked | |
|
Venture capital firm investing in seed & series A startups
|
Locked | Locked | Locked |
Investor details for FidoCure
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by FidoCure
Investment portfolio details for FidoCure
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - FidoCure
Detailed financials for FidoCure
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Fidocure Comparisons
Peer comparison for FidoCure
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of FidoCure
FidoCure operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Volition, Dognosis, MetaDx, Betternostic and CanCan Diagnostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Volition is focused on developing epigenetic diagnostic solutions.
|
|
| Locked | Locked | Locked |
Canine olfaction AI is developed for breath-based disease detection.
|
|
| Locked | Locked | Locked |
Developer of AI-based diagnostic solution for veterinary use
|
|
| Locked | Locked | Locked |
Canine oncology is diagnosed and predicted using AI-driven biomarker analysis.
|
|
| Locked | Locked | Locked |
Develops blood tests for early detection and monitoring of canine cancer through DNA analysis.
|
Detailed competitors of FidoCure
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Fidocure
Complete news archive for FidoCure
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about FidoCure
FidoCure was founded in 2016 and raised its 1st funding round 4 years after it was founded.
FidoCure is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
FidoCure is a funded company, having raised a total of $10M across 2 funding rounds to date.
As of Dec 31, 2024, the latest employee count at FidoCure is 10.
Digital platform transforming canine cancer care through AI-driven precision medicine. It provides genomics database which uses genomic testing to offer veterinarians with data, enabling to tailor cancer therapies for individual dog patient. It also provides veterinary services such as medications, therapies, and more for pets. It harness data from naturally occurring canine cancers via next-generation sequencing and clinical information. It proprietary learning database for canine cancer. It offers is pioneering first-in-class care for canine cancer, It represents the need for pet dogs. by connecting human and veterinary oncology.
FidoCure offers Genomic Testing Platform and AI-Driven Treatment Recommendations.
FidoCure has 7 investors. Key investors include Lerer Hippeau, Global Brain, Polaris Partners, Borealis Ventures, and Y Combinator.